FA
BSX icon

Friess Associates’s Boston Scientific BSX Stock Holding History

Friess Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,000
Closed -$71K – 122
2018
Q4 		$71K Buy
+2,000
New +$72.5K 0.01% 115
2017
Q2 		– Sell
-575,000
Closed -$14.3M – 109
2017
Q1 		$14.3M Buy
+575,000
New +$14M 1.35% 35
2016
Q4 		– Sell
-639,205
Closed -$15.2M – 147
2016
Q3 		$15.2M Hold
639,205
– – 1.47% 28
2016
Q2 		$14.9M Sell
639,205
-303,000
-32% -$6.55M 1.53% 29
2016
Q1 		$17.7M Buy
942,205
+120
+0% +$2.11K 1.77% 14
2015
Q4 		$17.4M Hold
942,085
– – 1.62% 16
2015
Q3 		$15.5M Hold
942,085
– – 1.44% 30
2015
Q2 		$16.7M Buy
+942,085
New +$16.8M 1.39% 32

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Friess Associates's BSX Position: Q1 2019 in Review

Friess Associates sold out of Boston Scientific (BSX) in Q1 2019, closing a stake of 2,000 shares — an estimated $71K sold.

Friess Associates first reported a position in BSX in Q2 2015 and held it in 8 quarters. The position peaked at $17.7M in Q1 2016. 789 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • Friess Associates reported no remaining Boston Scientific position as of Q1 2019 after selling out during the quarter.
  • Friess Associates sold 2,000 Boston Scientific shares in Q1 2019, an estimated $71K.
  • Friess Associates first reported a position in Boston Scientific in Q2 2015 and held it in 8 quarters.
  • Friess Associates's Boston Scientific position peaked at $17.7M in Q1 2016.
  • 789 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Friess Associates's 13F filing for Q1 2019, filed 15 May 2019.